In Canada, lung cancer remains the leading cause of cancer-related deaths, yet it remains one of the most underfunded in terms of research. To address this major issue, the Cancer Research Society invested $2,5 million in translational research on this disease.
This prrogram supports 5 translational research projects that will contribute to:
This major investment was made possible by the exceptional generosity of donors, including the Fondation Famille Gosselin, The Molson Foundation, the Lung Health Foundation and the George Papadopoulos Memorial Fund. It reflects a deep commitment to research and innovation, with the hope of offering a brighter future to those affected.
Forms will be available once a funding decision has been made.
